$4.2 Billion Global Nucleic Acid Isolation and Purification Market (2020 – 2027) – ResearchAndMarkets.com
March 16, 2020DUBLIN–(BUSINESS WIRE)–The “Nucleic Acid Isolation and Purification Market Size, Share & Trends Analysis Report by Product, by Type (DNA, RNA), by Application, by Method (Magnetic Bead, Reagent), by End Use, by Region, and Segment Forecasts, 2020 – 2027” report has been added to ResearchAndMarkets.com’s offering.
The global nucleic acid isolation and purification market size is expected to reach USD 4.2 billion by 2027, growing at a CAGR of 7.2% during the forecast period according to this report.
Ongoing developments of automated nucleic acid extraction systems designed for high-throughput sample processing have significantly simplified the isolation of DNA and RNA, thereby providing lucrative avenues for market growth. These systems potentially reduce the labor costs and time, increase worker safety, laboratory efficiency, reproducibility, and quality of results.
The growing popularity of biopharmaceuticals has led to the development of nucleic acid-based products, such as DNA vaccines, small interfering RNA, and antisense oligonucleotides. These products are applied in therapeutic techniques, such as gene therapy and anti-sense technology, as a powerful tool for medical practitioners to treat cancer, genetic, and infectious diseases. This has boosted the adoption of DNA or RNA isolation techniques in the market.
Further key findings from the report suggest:
- The instruments segment is expected to grow at a lucrative pace due to the advent of automated extraction systems resulting in high performance and lower cost for DNA extraction
- DNA isolation methods accounted for the largest revenue share and are anticipated to witness the fastest progress rate due to ongoing discoveries of simple, rapid, and inexpensive methods
- The high adoption rate of magnetic bead methods is attributive to its largest revenue share
- This is because the method can isolate nucleic acids directly from the crude sample without much processing
- This method is also expected to witness the fastest CAGR owing to the development of functionalized magnetic particles that have been incorporated in buffer systems to provide rapid and efficient extraction
- Oncology application is projected to witness a lucrative growth rate as liquid biopsy techniques and patient-tailored therapies are gaining traction for cancer diagnosis
- Hospitals and diagnostic centers accounted for the largest share in 2019, in terms of revenue
- The high incidence rate of genetic and inherited diseases has increased the usage of nucleic acid isolation in early and accurate diagnosis of these conditions in hospitals
Key Topics Covered:
Chapter 1 Research Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping for Method, 2019
3.2 Nucleic Acid Isolation & Purification Market: Technology Trends
3.2.1 Technology trends
3.2.2 Outsourcing & contract manufacturing trends
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing incidence of cancer, genetic disorders, and infectious diseases
3.3.1.2 Increase in public-private funding on biotechnology and life sciences research
3.3.1.3 Advancements in automation
3.3.1.4 Growth in NGS technologies
3.3.1.5 Growing demand for genetically modified crops and organisms
3.3.2 Market restraint analysis
3.3.2.1 Expensive instruments and consequent low penetration in emerging countries
3.3.2.2 Challenges related to the use of big data and bioinformatics
3.4 Nucleic Acid Isolation & Purification Market – SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.5 Industry Analysis – Porter’s
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 Agreement
3.6.2 Product developments
3.6.3 Merger & acquisition
3.6.4 Collaboration & partnership
Chapter 4 Nucleic Acid Isolation & Purification Market: Product Estimates & Trend Analysis
4.1 Nucleic Acid Isolation & Purification Market: Product Movement Analysis
4.2 Kits & Reagents
4.3 Instruments
Chapter 5 Nucleic Acid Isolation & Purification Market: Type Estimates & Trend Analysis
5.1 Nucleic Acid Isolation & Purification Market: Type Movement Analysis
5.2 DNA Isolation & Purification
5.3 RNA Isolation & Purification
Chapter 6 Nucleic Acid Isolation & Purification Market: Method Estimates & Trend Analysis
6.1 Nucleic Acid Isolation & Purification Market: Method Movement Analysis
6.2 Column Based Isolation & Purification
6.3 Magnetic Bead Based Isolation & Purification
6.4 Reagent Based Isolation & Purification
6.5 Other Methods
Chapter 7 Nucleic Acid Isolation & Purification Market: Applications Estimates & Trend Analysis
7.1 Nucleic Acid Isolation & Purification Market: Application Movement Analysis
7.2 Oncology
7.3 Precision Medicines
7.4 Diagnostics
7.5 Drug Discovery & Development
7.6 Agriculture & Animal Research
7.7 Other Applications
Chapter 8 Nucleic Acid Isolation & Purification Market: End-use Estimates & Trend Analysis
8.1 Nucleic Acid Isolation & Purification Market: End-use Movement Analysis
8.2 Academic Research Institutes
8.3 Pharmaceutical & Biotechnology Companies
8.4 Contract Research Organizations
8.5 Hospitals and Diagnostic Centers
8.6 Other End-use
Chapter 9 Nucleic Acid Isolation & Purification Market: Regional Estimates & Trend Analysis, by Product, Type, Method, Application, & End-use
9.1 Nucleic Acid Isolation & Purification Market Share by Regions, 2019 & 2027
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Latin America
9.6 MEA
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Recent Developments & Impact Analysis, by Key Market Participants
10.3 Public Companies
10.3.1 Company market position analysis
10.4 Private Companies
10.4.1 List of key emerging companies
10.5 Strategy Framework
10.6 Company Profiles
10.6.1 QIAGEN
10.6.2 Thermo Fisher Scientific, Inc.
10.6.3 Illumina, Inc.
10.6.4 Danaher
10.6.5 F. Hoffmann-La Roche Ltd.
10.6.6 Merck KGaA
10.6.7 Agilent Technologies, Inc.
10.6.8 Bio-Rad Laboratories, Inc.
10.6.9 GE Healthcare
10.6.10 Takara Bio USA Holdings, Inc.
10.6.11 Promega Corporation
10.6.12 Norgen Biotek Corp.
10.6.13 New England Biolabs
10.6.14 AUTOGEN INC.
10.6.15 LGC Biosearch Technologies
10.6.16 Biogenuix
10.6.18 MagGenome
10.6.19 Axon Scientific Sdn. Bhd.
10.6.20 Abcam plc
For more information about this report visit https://www.researchandmarkets.com/r/x9zyjx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900